Cheryl Barton

Innovative solutions are making personalized cell and gene therapies accessible to all.

New routes to cancer treatment can be found with the help of tumor-infiltrating lymphocyte (TIL) therapies.

What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?

Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.

TreeFrog Therapeutics is leaping ahead in cell therapies through resources such as new technologies and investor partnerships.